Wuhan Thalys Med Tech Co Ltd (603716) — Cash Flow Reinvestment Rate
Wuhan Thalys Med Tech Co Ltd (603716) has a Cash Flow Reinvestment Rate of 0.03x as of September 2025, reinvesting CN¥1.57 Million (capex CN¥1.57 Million ) from operating cash flow of CN¥54.57 Million. Explore Wuhan Thalys Med Tech Co Ltd capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Wuhan Thalys Med Tech Co Ltd Cash Flow Reinvestment Rate (2012–2024)
Historical reinvestment intensity for Wuhan Thalys Med Tech Co Ltd across 9 annual periods. Also explore Wuhan Thalys Med Tech Co Ltd asset portfolio for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Wuhan Thalys Med Tech Co Ltd (2012–2024)
Year-by-year capital reinvestment analysis for Wuhan Thalys Med Tech Co Ltd. For live market cap and broader valuation context, see Wuhan Thalys Med Tech Co Ltd stock valuation.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.51x | CN¥50.33 Million | CN¥99.60 Million | CN¥23.21 Million | ▲ +41.5% |
| 2023 | 0.36x | CN¥44.94 Million | CN¥125.89 Million | CN¥40.83 Million | ▼ -87.5% |
| 2022 | 2.85x | CN¥80.02 Million | CN¥28.12 Million | CN¥54.64 Million | ▼ -90.3% |
| 2020 | 29.43x | CN¥292.68 Million | CN¥9.94 Million | CN¥127.70 Million | ▲ +1449.0% |
| 2019 | 1.90x | CN¥178.47 Million | CN¥93.92 Million | CN¥96.49 Million | ▲ +116.5% |
| 2015 | 0.88x | CN¥40.47 Million | CN¥46.11 Million | CN¥40.47 Million | ▼ -16.8% |
| 2014 | 1.06x | CN¥31.73 Million | CN¥30.07 Million | CN¥31.73 Million | ▼ 0.0% |
| 2013 | 1.06x | CN¥34.35 Million | CN¥32.54 Million | CN¥34.35 Million | ▼ -93.1% |
| 2012 | 15.20x | CN¥41.04 Million | CN¥2.70 Million | CN¥41.04 Million | — |